The potential reclassification of cannabinoids, particularly at the federal level, is generating considerable anticipation within the market. A shift away from Schedule I status, often viewed as outdated and hindering https://janeqxkl524335.wikimidpoint.com/6435528/pot_rescheduling_a_expansion_catalyst